{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:49:57Z","timestamp":1770349797726,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":2247,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","award":["QP85GF13"],"award-info":[{"award-number":["QP85GF13"]}],"id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","award":["R085193713"],"award-info":[{"award-number":["R085193713"]}],"id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","award":["R21"],"award-info":[{"award-number":["R21"]}],"id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.fertnstert.2015.12.021","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T17:50:23Z","timestamp":1452275423000},"page":"1102-1110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Mifepristone inhibits extracellular matrix formation in uterine\u00a0leiomyoma"],"prefix":"10.1016","volume":"105","author":[{"given":"Amrita","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minnie","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Britten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeris","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Catherino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2015.12.021_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.sult.2008.12.002","article-title":"Image-guided thermal therapy of uterine fibroids","volume":"30","author":"Shen","year":"2009","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib2","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine leiomyoma: available medical treatments and new possible therapeutic options","volume":"98","author":"Islam","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ogc.2014.09.009","article-title":"Clinical management of leiomyoma","volume":"42","author":"Owen","year":"2015","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.fertnstert.2014.07.008","article-title":"Alternative therapies in management of leiomyomas","volume":"102","author":"Patel","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/rp.57.1.339","article-title":"Reproductive functions of progesterone receptors","volume":"57","author":"Conneely","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib7","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/humupd\/dmu056","article-title":"Role of nuclear progesterone receptor isoforms in uterine pathophysiology","volume":"21","author":"Patel","year":"2015","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejogrb.2012.07.023","article-title":"Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids","volume":"165","author":"Talaulikar","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/humrep\/9.suppl_1.116","article-title":"Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids","volume":"9","author":"Kettel","year":"1994","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2006.11.094","article-title":"A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata","volume":"87","author":"Chwalisz","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.fertnstert.2014.02.008","article-title":"Long-term treatment of uterine fibroids with ulipristal acetate","volume":"101","author":"Donnez","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","article-title":"Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study","volume":"95","author":"Nieman","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1023\/A:1025725716343","article-title":"Antiprogestin pharmacodynamics, pharmacokinetics, and metabolism: implications for their long-term use","volume":"25","author":"Jang","year":"1997","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.17772\/gp\/1642","article-title":"Applicability of selective progesterone receptor modulators in the treatment of uterine leiomyomata and their future role in the field of gynecology","volume":"84","author":"Brazert","year":"2013","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib18","first-page":"36","article-title":"Mifepristone: current knowledge and emerging prospects","volume":"112","author":"Kakade","year":"2014","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib19","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0015-0282(02)03378-2","article-title":"Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue","volume":"78","author":"Wu","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib20","first-page":"227","article-title":"Effect of mifepristone on the expression of progesterone receptor messenger RNA and protein in uterine leiomyomata","volume":"33","author":"Sun","year":"1998","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib21","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.fertnstert.2013.08.039","article-title":"Effects of mifepristone on uterine leiomyomas in premenopausal women: a meta-analysis","volume":"100","author":"Shen","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/IJWH.S42770","article-title":"Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial","volume":"5","author":"Esteve","year":"2013","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0033-1348896","article-title":"Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma","volume":"31","author":"Catherino","year":"2013","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/BJ20111996","article-title":"Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition","volume":"443","author":"Carrino","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.fertnstert.2006.08.111","article-title":"Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays","volume":"87","author":"Malik","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib26","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.fertnstert.2012.02.037","article-title":"Development and validation of a three-dimensional in\u00a0vitro model for uterine leiomyoma and patient-matched myometrium","volume":"97","author":"Malik","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib27","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1177\/1933719114545240","article-title":"Leiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fasudil, a rho-kinase inhibitor, when compared to 2-dimensional cultures","volume":"21","author":"Malik","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.fertnstert.2014.03.042","article-title":"Liarozole inhibits transforming growth factor-\u03b23\u2013mediated extracellular matrix formation in human three-dimensional leiomyoma cultures","volume":"102","author":"Levy","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2265.2008.03207.x","article-title":"Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells","volume":"68","author":"Malik","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib30","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004347-198506000-00001","article-title":"The effect of progestins on the mitotic activity of uterine fibromyomas","volume":"4","author":"Tiltman","year":"1985","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/deh146","article-title":"Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells","volume":"19","author":"Yamada","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib34","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/humrep\/dep100","article-title":"Mifepristone for treatment of uterine leiomyoma: a prospective randomized placebo controlled trial","volume":"24","author":"Engman","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1479-828X.2008.00931.x","article-title":"Low-dose mifepristone in treatment of uterine leiomyoma: a randomised double-blind placebo-controlled clinical trial","volume":"49","author":"Bagaria","year":"2009","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0015-0282(16)57678-X","article-title":"Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect","volume":"64","author":"Murphy","year":"1995","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib37","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/01.AOG.0000127622.63269.8b","article-title":"Systemic review of mifepristone for the treatment of uterine Leiomyomata","volume":"103","author":"Steubauer","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib38","first-page":"1217","article-title":"An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial","volume":"76","author":"Carr","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12079-014-0234-x","article-title":"Matrix production and remodeling as therapeutic targets for uterine leiomyoma","volume":"8","author":"Fujisawa","year":"2014","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib41","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.fertnstert.2012.07.1123","article-title":"Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production","volume":"98","author":"Britten","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib42","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0955-0674(02)00375-7","article-title":"Versican: a versatile extracellular matrix proteoglycan in cell biology","volume":"14","author":"Wight","year":"2002","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib43","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor \u03b23 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib44","first-page":"74","article-title":"A putative role of versican in uterine leiomyomas","volume":"36","author":"Ohara","year":"2009","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/gcc.20035","article-title":"Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids","volume":"40","author":"Catherino","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.fertnstert.2015.12.021_bib46","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1016-8478(23)17419-X","article-title":"Spatio-temporal expression and regulation of dermatopontin in the early pregnant mouse uterus","volume":"22","author":"Kim","year":"2006","journal-title":"Mol Cells"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028215021998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028215021998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T11:25:06Z","timestamp":1768649106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028215021998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S0015028215021998"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2015.12.021","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mifepristone inhibits extracellular matrix formation in uterine\u00a0leiomyoma","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2015.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}